A new method of Wilms' tumor gene WT1 quantitative assay (WT1 assay) based on real-time PCR for the detection of minimal residual disease (MRD) in patients with leukemia and myelodysplastic syndromes (MDS)

被引：0
|
作者：
Tamaki, H
Ogawa, H
Oka, Y
Soma, T
Sugiyama, H
机构：
[1] Osaka Univ, Grad Sch Med, Dept Mol Med, Suita, Osaka 565, Japan
[2] Osaka Univ, Grad Sch Med, Dept Clin Lab Sci, Suita, Osaka 565, Japan
[3] Osaka Minami Natl Hosp, Dept Med, Osaka, Japan
来源：
LEUKEMIA | 2001年 / 15卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2024 / 2024
页数：1
相关论文
共 50 条
  • [21] Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients
    D Cilloni
    E Gottardi
    D De Micheli
    A Serra
    G Volpe
    F Messa
    G Rege-Cambrin
    A Guerrasio
    M Divona
    F Lo Coco
    G Saglio
    Leukemia, 2002, 16 : 2115 - 2121
  • [22] Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients
    Cilloni, D
    Gottardi, E
    De Micheli, D
    Serra, A
    Volpe, G
    Messa, F
    Rege-Cambrin, G
    Guerrasio, A
    Divona, M
    Lo Coco, F
    Saglio, G
    LEUKEMIA, 2002, 16 (10) : 2115 - 2121
  • [23] METHODOLOGICAL EVALUATION OF OTSUKA® WT1 REAL-TIME FLUORESCENCE COMMERCIAL KIT FOR THE QUANTITATIVE DETECTION OF WT1 EXPRESSION
    Ma, Xiaoli
    Wang, Fang
    Wu, Qisheng
    Wang, Na
    Zhou, Lin
    Zhang, Ying
    Cao, Chunye
    Liu, Hongxing
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 : 105 - 106
  • [24] EARLY ASSESSMENT OF MINIMAL RESIDUAL DISEASE (MRD) BY OPTIMIZED REAL-TIME QUANTITATIVE PCR (RQ-PCR) ASSAY FOR DETECTION OF WT1 TRANSCRIPTS PROVIDES AN INDEPENDENT PREDICTOR OF DISEASE RELAPSE IN ACUTE MYELOID LEUKEMIA: A EUROPEAN LEUKEMIANET (ELN) STUDY
    Cilloni, D.
    Renneville, A.
    Hermitte, F.
    Hills, R. K.
    Daly, S.
    Jovanovic, J.
    Gottardi, E.
    Fava, M.
    Schnittger, S.
    Weiss, T.
    Izzo, B.
    Nomdedeu, J.
    van der Heijden, A.
    van der Reijden, B.
    van der Velden, V.
    Rohon, P.
    Ommen, H.
    Polak, J.
    Jansen, J.
    Preudhomme, C.
    Saglio, G.
    Grimwade, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 169 - 169
  • [25] QUANTITATIVE ASSESSMENT OF WT1 EXPRESSION FOR MONITORING MINIMAL RESIDUAL DISEASE IN ACUTE LEUKEMIA PATIENTS
    Shmunk, I.
    Koneva, E.
    Lyubchenko, M.
    Rusakov, M.
    Kiseleva, M.
    Markova, Y.
    Zalcharova, M.
    Korobitsina, O.
    Korobkin, A.
    Burmistrova, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 10 - 10
  • [26] Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection
    Cilloni, D
    Gottardi, E
    Fava, M
    Messa, F
    Carturan, S
    Busca, A
    Guerrasio, A
    Saglio, G
    BLOOD, 2003, 102 (02) : 773 - 774
  • [27] Quantitative Assessment of Wilms Tumor 1 (WT1) Gene Transcripts in Egyptian Acute Lymphoblastic Leukemia Patients
    Sadek, Hoda Ali
    El-Metnawey, Wafaa Hassan
    Shaheen, Iman Abdel-Mohsen
    Korshied, Mervat Mamdouh
    Mohamed, Azza Sobieh
    JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (08) : 1258 - 1262
  • [28] Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
    Cilloni, Daniela
    Renneville, Aline
    Hermitte, Fabienne
    Hills, Robert K.
    Daly, Sarah
    Jovanovic, Jelena V.
    Gottardi, Enrico
    Fava, Milena
    Schnittger, Susanne
    Weiss, Tamara
    Izzo, Barbara
    Nomdedeu, Josep
    van der Heijden, Adrian
    van der Reijden, Bert A.
    Jansen, Joop H.
    van der Velden, Vincent H. J.
    Ommen, Hans
    Preudhomme, Claude
    Saglio, Giuseppe
    Grimwade, David
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) : 5195 - 5201
  • [29] WT1 gene expression:: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?
    Bader, P
    Niemeyer, C
    Weber, G
    Coliva, T
    Rossi, V
    Kreyenberg, H
    Gerecke, A
    Biondi, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (01) : 25 - 28
  • [30] Utility of WT1 as a reliable tool for the detection of minimal residual disease in children with leukemia
    Kletzel, M
    Olzewski, M
    Huang, W
    Chou, PM
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2002, 5 (03) : 269 - 275
12345